Supernus Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 705 | 0.0% | 14,195 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 682 | 0.0% | 14,280 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 453 | 0.0% | 14,375 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 433 | 0.0% | 13,214 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 426 | 0.0% | 11,788 | 12/31/2024 |
| 2024 Q3 | 11/7/2024 | 367 | 0.0% | 11,779 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 317 | 0.0% | 11,846 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 402 | 0.0% | 11,798 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 341 | 0.0% | 11,789 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 1,006 | 0.0% | 36,498 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 1,851 | 0.0% | 61,578 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 2,074 | 0.0% | 57,238 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 2,064 | 0.0% | 57,854 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 1,650 | 0.0% | 48,740 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,408 | 0.0% | 48,691 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 1,482 | 0.0% | 45,847 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 1,172 | 0.0% | 40,194 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 1,075 | 0.0% | 40,296 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 1,253 | 0.0% | 40,688 | 6/30/2021 |
| 2021 Q1 | 5/12/2021 | 1,069 | 0.0% | 40,814 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 1,027 | 0.0% | 40,813 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 852 | 0.0% | 40,866 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 628 | 0.0% | 26,447 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 475 | 0.0% | 26,396 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 422 | 0.0% | 17,786 | 12/31/2019 |